Atezolizumab Monotherapy or Plus Chemotherapy in First-Line Treatment for Advanced Non-Small Cell Lung Cancer Patients: A Meta-Analysis

Li, DN; Lu, WQ; Yang, BW; Zhang, LY; Jin, B; Wang, S; Che, XF; Li, C; Liu, YP; Qu, XJ

Liu, YP; Qu, XJ (corresponding author), China Med Univ, Dept Med Oncol, Hosp 1, Shenyang, Peoples R China.; Liu, YP; Qu, XJ (corresponding author), China Med Univ, Key Lab Anticanc Drugs & Biotherapy Liaoning Prov, Hosp 1, Shenyang, Peoples R China.; Liu, YP; Qu, XJ (corresponding author), Liaoning Prov Clin Res Ctr Canc, Shenyang, Peoples R China.

FRONTIERS IN IMMUNOLOGY, 2021; 12 ():

Abstract

Background Atezolizumab plus chemotherapy has been recommended as a first-line treatment option for patients with advanced non-small cell lung carcino......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索